SABCS: Seagen outlines Tukysa's value alongside Roche's ADC in breast cancer. But FDA path remains unclear
SABCS: Seagen outlines Tukysa's value alongside Roche's ADC in breast cancer. But FDA path remains unclear
aliu
Tue, 12/05/2023 - 15:23
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
